首页 > 最新文献

Langenbeck's Archives of Surgery最新文献

英文 中文
A novel circumferential continuous reinforcing suture for anastomosis after laparoscopic resection for rectal cancer and sigmoid cancer: a retrospective case-controlled study. 腹腔镜直肠癌和乙状结肠癌切除术后用于吻合的新型周缘连续加固缝合线:一项回顾性病例对照研究。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-12 DOI: 10.1007/s00423-024-03494-7
Jianhong Peng, Weili Zhang, Chi Zhou, Leen Liao, Linjie Zhang, Wenhua Fan, Zhizhong Pan, Zhenhai Lu, Junzhong Lin

Introduction: This study aimed to investigate the effectiveness of a novel method for anastomosis reinforcement to minimize the occurrence of anastomotic complications after surgical resection of rectal and sigmoid cancer.

Methods: We recruited 378 patients who underwent laparoscopic rectal anterior resection of rectal cancer and sigmoid cancer in SYSUCC. The occurrence rates of intraoperative bleeding, operation time, and postoperative anastomotic complications were compared between the treatment group receiving anastomotic reinforcement and the control group without anastomotic reinforcement.

Results: The incidence of anastomotic leakage in the treatment group was significantly lower than that in the control group (1.59% vs. 11.64%, p < 0.001). Following the application of inverse probability of treatment weighting (IPTW) to adjust for factors influencing the occurrence of anastomotic leakage, the incidence of anastomotic leakage remained significantly lower in the treatment group compared to the control group (2.54% vs. 12.08%, p < 0.001).

Conclusion: The circumferential continuous anastomosis reinforcing suture method, recommended for laparoscopic surgery for rectal and sigmoid cancer, has the potential to effectively minimize the occurrence of anastomotic complications.

引言本研究旨在探讨一种新的吻合口加固方法对减少直肠癌和乙状结肠癌手术切除后吻合口并发症发生的有效性:方法:我们招募了378名在SYSUCC接受腹腔镜直肠前切除术的直肠癌和乙状结肠癌患者。比较了接受吻合口加固的治疗组和未接受吻合口加固的对照组的术中出血率、手术时间和术后吻合口并发症的发生率:结果:治疗组的吻合口漏发生率明显低于对照组(1.59% 对 11.64%,P推荐用于直肠癌和乙状结肠癌腹腔镜手术的环形连续吻合口加固缝合法,有可能有效地减少吻合口并发症的发生。
{"title":"A novel circumferential continuous reinforcing suture for anastomosis after laparoscopic resection for rectal cancer and sigmoid cancer: a retrospective case-controlled study.","authors":"Jianhong Peng, Weili Zhang, Chi Zhou, Leen Liao, Linjie Zhang, Wenhua Fan, Zhizhong Pan, Zhenhai Lu, Junzhong Lin","doi":"10.1007/s00423-024-03494-7","DOIUrl":"https://doi.org/10.1007/s00423-024-03494-7","url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to investigate the effectiveness of a novel method for anastomosis reinforcement to minimize the occurrence of anastomotic complications after surgical resection of rectal and sigmoid cancer.</p><p><strong>Methods: </strong>We recruited 378 patients who underwent laparoscopic rectal anterior resection of rectal cancer and sigmoid cancer in SYSUCC. The occurrence rates of intraoperative bleeding, operation time, and postoperative anastomotic complications were compared between the treatment group receiving anastomotic reinforcement and the control group without anastomotic reinforcement.</p><p><strong>Results: </strong>The incidence of anastomotic leakage in the treatment group was significantly lower than that in the control group (1.59% vs. 11.64%, p < 0.001). Following the application of inverse probability of treatment weighting (IPTW) to adjust for factors influencing the occurrence of anastomotic leakage, the incidence of anastomotic leakage remained significantly lower in the treatment group compared to the control group (2.54% vs. 12.08%, p < 0.001).</p><p><strong>Conclusion: </strong>The circumferential continuous anastomosis reinforcing suture method, recommended for laparoscopic surgery for rectal and sigmoid cancer, has the potential to effectively minimize the occurrence of anastomotic complications.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"305"},"PeriodicalIF":2.1,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic variants in patients with multiple arterial aneurysms. 多发性动脉瘤患者的基因变异。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-09 DOI: 10.1007/s00423-024-03488-5
Daniel Körfer, Caspar Grond-Ginsbach, Andreas S Peters, Sebastian Burkart, Maja Hempel, Christian P Schaaf, Dittmar Böckler, Philipp Erhart

Purpose: The aim of this study was to identify causal genetic variants in patients with multiple arterial aneurysms.

Methods: From a total cohort of 3107 patients diagnosed with an arterial aneurysm from 2006 to 2016, patients with known hereditary connective tissue diseases, vasculitis, or other arterial pathologies (n = 918) were excluded. Of the remaining cohort (n = 2189), patients with at least 4 aneurysms at different arterial locations (n = 143) were included. Nine blood samples of respective patients were available and derived from the institutional vascular biomaterial bank, and analyzed by whole exome sequencing (WES). Possible candidate variants were selected based on in silico predictions: (I) Truncating variants or (II) Variants that were classified as likely pathogenic (SIFT score < 0.05 or PolyPhen score > 0.9) and with low (< 0.001) or unknown gnomAD allele frequency. The human genome databases GeneCards and MalaCards were used to correlate the variants with regard to possible associations with vascular diseases.

Results: A total of 24 variants in 23 different genes associated with vascular diseases were detected in the cohort. One patient with eight aneurysms was heterozygous for a variant in SMAD3, for which pathogenic variants are phenotypically associated with Loeys-Dietz syndrome 3. A heterozygous variant in TNXB was found in a patient with five aneurysms. Homozygous or compound heterozygous pathogenic variants in this gene are associated with Ehlers-Danlos syndrome (classical-like). Another patient with six aneurysms carried two heterozygous TET2 variants together with a heterozygous PPM1D variant. Pathogenic variants in these genes are associated with clonal hematopoiesis of indeterminate potential (CHIP), a known risk factor for cardiovascular disease.

Conclusion: All nine patients in this study carried variants in genes associated with vascular diseases. Current knowledge of the specific variants is insufficient to classify them as pathogenic at the present time, underlining the need for a better understanding of the consequences of genetic variants. WES should be considered for patients with multiple arterial aneurysms to detect germline variants and to improve clinical management for the individual and family members.

目的:本研究旨在确定多发性动脉瘤患者的致病基因变异:在2006年至2016年期间确诊为动脉动脉瘤的3107名患者中,排除了已知患有遗传性结缔组织疾病、血管炎或其他动脉病变的患者(918人)。在剩余的队列(n = 2189)中,纳入了在不同动脉位置至少患有 4 个动脉瘤的患者(n = 143)。从机构的血管生物材料库中获得了9份相应患者的血液样本,并通过全外显子组测序(WES)进行了分析。可能的候选变异是根据硅学预测筛选出来的:(I) 截断变异或 (II) 被归类为可能致病(SIFT 得分为 0.9)且低致病性的变异:队列中共检测到与血管疾病相关的 23 个不同基因中的 24 个变异。其中一名患有 8 个动脉瘤的患者是 SMAD3 基因变异的杂合子,该基因的致病变异在表型上与 Loeys-Dietz 综合征 3 相关。在一名有五个动脉瘤的患者中,发现了 TNXB 的杂合变体。该基因的同卵或复合杂合致病变体与埃勒斯-丹洛斯综合征(经典样)有关。另一名有六个动脉瘤的患者携带两个杂合 TET2 变异基因和一个杂合 PPM1D 变异基因。这些基因的致病变异与不确定潜能克隆性造血(CHIP)有关,而CHIP是心血管疾病的已知风险因素:本研究中的九名患者均携带与血管疾病相关的基因变异。目前对特定变异基因的了解还不足以将其归类为致病基因,因此需要更好地了解基因变异的后果。应考虑对多发性动脉瘤患者进行 WES 检测,以发现种系变异,改善个人和家庭成员的临床管理。
{"title":"Genetic variants in patients with multiple arterial aneurysms.","authors":"Daniel Körfer, Caspar Grond-Ginsbach, Andreas S Peters, Sebastian Burkart, Maja Hempel, Christian P Schaaf, Dittmar Böckler, Philipp Erhart","doi":"10.1007/s00423-024-03488-5","DOIUrl":"10.1007/s00423-024-03488-5","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to identify causal genetic variants in patients with multiple arterial aneurysms.</p><p><strong>Methods: </strong>From a total cohort of 3107 patients diagnosed with an arterial aneurysm from 2006 to 2016, patients with known hereditary connective tissue diseases, vasculitis, or other arterial pathologies (n = 918) were excluded. Of the remaining cohort (n = 2189), patients with at least 4 aneurysms at different arterial locations (n = 143) were included. Nine blood samples of respective patients were available and derived from the institutional vascular biomaterial bank, and analyzed by whole exome sequencing (WES). Possible candidate variants were selected based on in silico predictions: (I) Truncating variants or (II) Variants that were classified as likely pathogenic (SIFT score < 0.05 or PolyPhen score > 0.9) and with low (< 0.001) or unknown gnomAD allele frequency. The human genome databases GeneCards and MalaCards were used to correlate the variants with regard to possible associations with vascular diseases.</p><p><strong>Results: </strong>A total of 24 variants in 23 different genes associated with vascular diseases were detected in the cohort. One patient with eight aneurysms was heterozygous for a variant in SMAD3, for which pathogenic variants are phenotypically associated with Loeys-Dietz syndrome 3. A heterozygous variant in TNXB was found in a patient with five aneurysms. Homozygous or compound heterozygous pathogenic variants in this gene are associated with Ehlers-Danlos syndrome (classical-like). Another patient with six aneurysms carried two heterozygous TET2 variants together with a heterozygous PPM1D variant. Pathogenic variants in these genes are associated with clonal hematopoiesis of indeterminate potential (CHIP), a known risk factor for cardiovascular disease.</p><p><strong>Conclusion: </strong>All nine patients in this study carried variants in genes associated with vascular diseases. Current knowledge of the specific variants is insufficient to classify them as pathogenic at the present time, underlining the need for a better understanding of the consequences of genetic variants. WES should be considered for patients with multiple arterial aneurysms to detect germline variants and to improve clinical management for the individual and family members.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"304"},"PeriodicalIF":2.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11464538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative recovery in peroral versus intravenous antibiotic treatment following laparoscopic appendectomy for complicated appendicitis: a substudy of a cluster randomized cluster crossover non-inferiority study. 腹腔镜阑尾切除术治疗复杂性阑尾炎后口服与静脉注射抗生素治疗的术后恢复情况:分组随机交叉非劣效研究的子研究。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-09 DOI: 10.1007/s00423-024-03491-w
Ahmed Abdirahman Mohamud, Walid Zeyghami, Jakob Kleif, Ismail Gögenur

Background: Acute appendicitis is the most common cause of abdominal pain requiring surgery, usually managed with laparoscopic appendectomy. In Denmark, the standard postoperative treatment for complicated cases involves intravenous antibiotics. This study compares peroral versus intravenous antibiotics in the context of fast-track surgery and Enhanced Recovery After Surgery (ERAS) protocols. Our objective is to evaluate the impact of peroral versus intravenous antibiotics on patient-reported outcomes following laparoscopic appendectomy for complicated appendicitis.

Methods: This was a sub-study within a broader Danish cluster-randomized non-inferiority trial conducted at Zealand University Hospital, focusing on adult patients undergoing laparoscopic appendectomy for complicated appendicitis. Participants were randomized into two groups: one receiving a three-day course of peroral antibiotics and the other intravenous antibiotics after surgery. Recovery quality was assessed on the third postoperative day using the Quality of Recovery-15 (QoR-15) questionnaire.

Results: The study included 54 patients, 23 in the peroral and 31 in the intravenous groups. The peroral group reported significantly better recovery outcomes, with higher QoR-15 scores (mean difference of 12 points, p < 0.001). They also experienced shorter hospital stays, averaging 47 h less than the intravenous group (p < 0.001). No significant differences between the groups were observed in readmissions or severe postoperative complications.

Conclusions: Peroral antibiotic administration after laparoscopic appendectomy for complicated appendicitis significantly improves patient recovery and reduces hospital stay compared to intravenous antibiotics. These results advocate a potential shift towards peroral antibiotic use in postoperative care, aligning with ERAS principles.

Trial registration number: ClinicalTrials.gov NCT04803422.

背景:急性阑尾炎是导致腹痛的最常见原因,需要进行手术治疗,通常采用腹腔镜阑尾切除术。在丹麦,复杂病例的标准术后治疗包括静脉注射抗生素。本研究比较了在快速手术和术后强化恢复(ERAS)方案下口服抗生素和静脉注射抗生素的效果。我们的目的是评估腹腔镜阑尾切除术治疗复杂性阑尾炎后,口服抗生素与静脉注射抗生素对患者报告结果的影响:这是在西兰大学医院进行的一项更广泛的丹麦分组随机非劣效性试验中的一项子研究,主要针对接受腹腔镜阑尾切除术治疗复杂性阑尾炎的成年患者。参与者被随机分为两组:一组在术后接受为期三天的口服抗生素治疗,另一组在术后接受静脉注射抗生素治疗。术后第三天使用恢复质量-15(QoR-15)问卷对恢复质量进行评估:研究包括 54 名患者,其中口服组 23 人,静脉注射组 31 人。口服组的恢复效果明显更好,QoR-15 得分更高(平均相差 12 分,P 结论:腹腔镜手术后口服抗生素的效果更好:腹腔镜阑尾切除术后口服抗生素治疗复杂性阑尾炎与静脉注射抗生素相比,能明显改善患者的恢复情况并缩短住院时间。这些结果表明,术后护理有可能转向口服抗生素,这符合ERAS原则:试验注册号:ClinicalTrials.gov NCT04803422。
{"title":"Postoperative recovery in peroral versus intravenous antibiotic treatment following laparoscopic appendectomy for complicated appendicitis: a substudy of a cluster randomized cluster crossover non-inferiority study.","authors":"Ahmed Abdirahman Mohamud, Walid Zeyghami, Jakob Kleif, Ismail Gögenur","doi":"10.1007/s00423-024-03491-w","DOIUrl":"10.1007/s00423-024-03491-w","url":null,"abstract":"<p><strong>Background: </strong>Acute appendicitis is the most common cause of abdominal pain requiring surgery, usually managed with laparoscopic appendectomy. In Denmark, the standard postoperative treatment for complicated cases involves intravenous antibiotics. This study compares peroral versus intravenous antibiotics in the context of fast-track surgery and Enhanced Recovery After Surgery (ERAS) protocols. Our objective is to evaluate the impact of peroral versus intravenous antibiotics on patient-reported outcomes following laparoscopic appendectomy for complicated appendicitis.</p><p><strong>Methods: </strong>This was a sub-study within a broader Danish cluster-randomized non-inferiority trial conducted at Zealand University Hospital, focusing on adult patients undergoing laparoscopic appendectomy for complicated appendicitis. Participants were randomized into two groups: one receiving a three-day course of peroral antibiotics and the other intravenous antibiotics after surgery. Recovery quality was assessed on the third postoperative day using the Quality of Recovery-15 (QoR-15) questionnaire.</p><p><strong>Results: </strong>The study included 54 patients, 23 in the peroral and 31 in the intravenous groups. The peroral group reported significantly better recovery outcomes, with higher QoR-15 scores (mean difference of 12 points, p < 0.001). They also experienced shorter hospital stays, averaging 47 h less than the intravenous group (p < 0.001). No significant differences between the groups were observed in readmissions or severe postoperative complications.</p><p><strong>Conclusions: </strong>Peroral antibiotic administration after laparoscopic appendectomy for complicated appendicitis significantly improves patient recovery and reduces hospital stay compared to intravenous antibiotics. These results advocate a potential shift towards peroral antibiotic use in postoperative care, aligning with ERAS principles.</p><p><strong>Trial registration number: </strong>ClinicalTrials.gov NCT04803422.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"303"},"PeriodicalIF":2.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy. 淋巴结比值作为胰十二指肠切除术后复发指标的临床意义。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-08 DOI: 10.1007/s00423-024-03481-y
Shinichiro Hasegawa, Hiroshi Wada, Masahiko Kubo, Yosuke Mukai, Manabu Mikamori, Hirofumi Akita, Norihiro Matsuura, Masatoshi Kitakaze, Yasunori Masuike, Takahito Sugase, Naoki Shinno, Takashi Kanemura, Hisashi Hara, Toshinori Sueda, Junichi Nishimura, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue

Background: The clinical significance of the lymph node ratio (LNR), the number of metastatic lymph nodes per dissected lymph node, has not been sufficiently clarified in ampullary cancer.

Methods: Among patients diagnosed histopathologically with ampullary cancer between 1980 and 2018, the study included 106 who underwent pathological radical resection by pancreaticoduodenectomy. The relationships between the LNR and metastatic lymph node sites and prognosis were examined.

Results: Multivariate analysis revealed that sex and lymph node metastasis were independent prognostic factors. In the 46 patients (43%) with metastatic lymph nodes, the LNR in the recurrence group was significantly higher than that in the non-recurrence group (0.15 ± 0.11 vs. 0.089 ± 0.071, p = 0.025). The receiver operating characteristic curve demonstrated that the LNR cut-off value, 0.07 (area under the curve = 0.70, sensitivity 81%, specificity 56%), was a significant indicator for recurrence (22% vs. 61%, p = 0.016) and prognosis (5-year survival: 48% vs. 83%, p = 0.028). Among the metastatic lymph node sites in the 46 positive cases, lymph node metastases developed from the peripancreatic head region (80%, 37/46) to the superior mesenteric artery (33%, 15/46) and para-aortic (11%, 5/46) regions.

Conclusion: Lymph node metastasis is an independent prognostic factor, and the LNR is a significant indicator for recurrence and prognosis in patients with ampullary cancer.

背景:淋巴结比率(LNR)是指每个切除淋巴结中转移淋巴结的数量:淋巴结比(LNR)是指每个切除淋巴结中转移淋巴结的数量,在胰壶腹癌中的临床意义尚未得到充分阐明:在1980年至2018年期间经组织病理学确诊的胰壶腹癌患者中,研究纳入了106名接受胰十二指肠切除术病理根治性切除的患者。研究了LNR和转移淋巴结部位与预后之间的关系:多变量分析显示,性别和淋巴结转移是独立的预后因素。在有淋巴结转移的 46 例患者(43%)中,复发组的 LNR 明显高于非复发组(0.15 ± 0.11 vs. 0.089 ± 0.071,P = 0.025)。接收器操作特征曲线显示,LNR 临界值 0.07(曲线下面积 = 0.70,敏感性 81%,特异性 56%)是复发(22% vs. 61%,p = 0.016)和预后(5 年生存率:48% vs. 83%,p = 0.028)的重要指标。在46例阳性病例的淋巴结转移部位中,淋巴结转移从胰头周围区域(80%,37/46)发展到肠系膜上动脉区域(33%,15/46)和主动脉旁区域(11%,5/46):结论:淋巴结转移是一个独立的预后因素,淋巴结转移率是衡量胰腺癌患者复发和预后的重要指标。
{"title":"The clinical significance of the lymph node ratio as a recurrence indicator in ampullary cancer after curative pancreaticoduodenectomy.","authors":"Shinichiro Hasegawa, Hiroshi Wada, Masahiko Kubo, Yosuke Mukai, Manabu Mikamori, Hirofumi Akita, Norihiro Matsuura, Masatoshi Kitakaze, Yasunori Masuike, Takahito Sugase, Naoki Shinno, Takashi Kanemura, Hisashi Hara, Toshinori Sueda, Junichi Nishimura, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue","doi":"10.1007/s00423-024-03481-y","DOIUrl":"https://doi.org/10.1007/s00423-024-03481-y","url":null,"abstract":"<p><strong>Background: </strong>The clinical significance of the lymph node ratio (LNR), the number of metastatic lymph nodes per dissected lymph node, has not been sufficiently clarified in ampullary cancer.</p><p><strong>Methods: </strong>Among patients diagnosed histopathologically with ampullary cancer between 1980 and 2018, the study included 106 who underwent pathological radical resection by pancreaticoduodenectomy. The relationships between the LNR and metastatic lymph node sites and prognosis were examined.</p><p><strong>Results: </strong>Multivariate analysis revealed that sex and lymph node metastasis were independent prognostic factors. In the 46 patients (43%) with metastatic lymph nodes, the LNR in the recurrence group was significantly higher than that in the non-recurrence group (0.15 ± 0.11 vs. 0.089 ± 0.071, p = 0.025). The receiver operating characteristic curve demonstrated that the LNR cut-off value, 0.07 (area under the curve = 0.70, sensitivity 81%, specificity 56%), was a significant indicator for recurrence (22% vs. 61%, p = 0.016) and prognosis (5-year survival: 48% vs. 83%, p = 0.028). Among the metastatic lymph node sites in the 46 positive cases, lymph node metastases developed from the peripancreatic head region (80%, 37/46) to the superior mesenteric artery (33%, 15/46) and para-aortic (11%, 5/46) regions.</p><p><strong>Conclusion: </strong>Lymph node metastasis is an independent prognostic factor, and the LNR is a significant indicator for recurrence and prognosis in patients with ampullary cancer.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"302"},"PeriodicalIF":2.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD). 终末期肾病(ESRD)甲状旁腺癌患者队列回顾。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-08 DOI: 10.1007/s00423-024-03496-5
Victoria Zheng, James Lee, Rajeev Parameswaran

Background and hypothesis: Parathyroid carcinoma (PTTC) is a rare malignant endocrine tumor seen in up to 1-2% of all cases of primary hyperparathyroidism. However, incidence of parathyroid carcinoma in renal hyperparathyroidism is a rare phenomenon. We aimed to evaluate the outcomes of PTTC in renal hyperparathyroidism published in the literature.

Methods: Cohort review of parathyroid cancer cases reported in Medline (via PubMed), COCHRANE and EMBASE between the period 1985 - 2023 in patients with renal hyperparathyroidism.

Results: A total of 48 patients (20 M: 28F), with a mean age of 49.8 (± 11.7 SD: range 20-75) years. Dialysis vintage was for a period of 8.9 (± 7.2; range 6 months to 40 years). The mean preoperative values were as follows: serum corrected calcium-2.87 IQR 2.56-3.01), PTH - 221.8 (IQR 86.6 -257.2 pmol/L) and serum phosphate - 2.07 (IQR 1.72-2.28) mmol/L. Preoperative imaging was in the form of ultrasound of the neck in 21 of 48 (44%), MIBI scan in 27/48 (56%), contrast enhanced computerized tomography in 14/48 (29%) and MRI neck in 1/48 (2%). The mean size of the cancer was 2.7 (± 1.35) cm and weight of the gland ranged between 0.9 to 4.98 g. 18/48 (37%) patients underwent a total parathyroidectomy and 30/48 (63%) had subtotal parathyroidectomy. En bloc excision of the tumour along with the thyroid along and central compartment lymph nodes was only performed in 12/48 (25%), of whom 9 (19%) had it performed at index surgery, whereas in the rest was done for persistent or recurrent disease. After a mean follow up of 34 months, 14 (29%) had local recurrence, 1 (2%) had distant metastasis to the skeletal system, and 12 (25%) to the lungs. Cohort mortality was 6 (13%) due to refractory hypercalcemia.

Conclusions: Parathyroid carcinoma in renal hyperparathyroidism is rare but when encountered, en bloc excision with parathyroidectomy provides the best chance of cure. Recurrences can be difficult to treat but may be needed to treat intractable hypercalcaemia.

背景和假设:甲状旁腺癌(PTTC)是一种罕见的恶性内分泌肿瘤,在所有原发性甲状旁腺功能亢进症病例中的发病率高达1%-2%。然而,肾性甲状旁腺功能亢进症中甲状旁腺癌的发病率却非常罕见。我们的目的是评估文献中发表的肾性甲状旁腺功能亢进症中PTTC的结果:对1985-2023年间Medline(通过PubMed)、COCHRANE和EMBASE中报道的肾性甲状旁腺功能亢进症患者甲状旁腺癌病例进行队列回顾:共有 48 名患者(20 名男性:28 名女性),平均年龄为 49.8 岁(± 11.7 SD:20-75 岁)。透析年限为 8.9 年(± 7.2;范围为 6 个月至 40 年)。术前平均值如下:血清校正钙-2.87 IQR 2.56-3.01),PTH-221.8(IQR 86.6 -257.2 pmol/L),血清磷酸盐-2.07(IQR 1.72-2.28)mmol/L。48 例患者中有 21 例(44%)接受了颈部超声波检查,27/48 例(56%)接受了 MIBI 扫描,14/48 例(29%)接受了造影剂增强型计算机断层扫描,1/48 例(2%)接受了颈部磁共振成像检查。18/48(37%)名患者接受了甲状旁腺全切除术,30/48(63%)名患者接受了甲状旁腺次全切除术。只有12/48(25%)的患者接受了肿瘤连同甲状腺和中央区淋巴结的整体切除术,其中9人(19%)是在首次手术时进行的,其余患者则是在病情持续或复发时进行的。平均随访34个月后,14例(29%)局部复发,1例(2%)远处转移至骨骼系统,12例(25%)转移至肺部。因难治性高钙血症导致的队列死亡率为6例(13%):结论:肾性甲状旁腺功能亢进症中的甲状旁腺癌非常罕见,但一旦发生,通过甲状旁腺切除术进行全切可获得最佳治愈效果。复发的甲状旁腺癌可能很难治疗,但可能需要治疗难治性高钙血症。
{"title":"Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD).","authors":"Victoria Zheng, James Lee, Rajeev Parameswaran","doi":"10.1007/s00423-024-03496-5","DOIUrl":"10.1007/s00423-024-03496-5","url":null,"abstract":"<p><strong>Background and hypothesis: </strong>Parathyroid carcinoma (PTTC) is a rare malignant endocrine tumor seen in up to 1-2% of all cases of primary hyperparathyroidism. However, incidence of parathyroid carcinoma in renal hyperparathyroidism is a rare phenomenon. We aimed to evaluate the outcomes of PTTC in renal hyperparathyroidism published in the literature.</p><p><strong>Methods: </strong>Cohort review of parathyroid cancer cases reported in Medline (via PubMed), COCHRANE and EMBASE between the period 1985 - 2023 in patients with renal hyperparathyroidism.</p><p><strong>Results: </strong>A total of 48 patients (20 M: 28F), with a mean age of 49.8 (± 11.7 SD: range 20-75) years. Dialysis vintage was for a period of 8.9 (± 7.2; range 6 months to 40 years). The mean preoperative values were as follows: serum corrected calcium-2.87 IQR 2.56-3.01), PTH - 221.8 (IQR 86.6 -257.2 pmol/L) and serum phosphate - 2.07 (IQR 1.72-2.28) mmol/L. Preoperative imaging was in the form of ultrasound of the neck in 21 of 48 (44%), MIBI scan in 27/48 (56%), contrast enhanced computerized tomography in 14/48 (29%) and MRI neck in 1/48 (2%). The mean size of the cancer was 2.7 (± 1.35) cm and weight of the gland ranged between 0.9 to 4.98 g. 18/48 (37%) patients underwent a total parathyroidectomy and 30/48 (63%) had subtotal parathyroidectomy. En bloc excision of the tumour along with the thyroid along and central compartment lymph nodes was only performed in 12/48 (25%), of whom 9 (19%) had it performed at index surgery, whereas in the rest was done for persistent or recurrent disease. After a mean follow up of 34 months, 14 (29%) had local recurrence, 1 (2%) had distant metastasis to the skeletal system, and 12 (25%) to the lungs. Cohort mortality was 6 (13%) due to refractory hypercalcemia.</p><p><strong>Conclusions: </strong>Parathyroid carcinoma in renal hyperparathyroidism is rare but when encountered, en bloc excision with parathyroidectomy provides the best chance of cure. Recurrences can be difficult to treat but may be needed to treat intractable hypercalcaemia.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"300"},"PeriodicalIF":2.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New definition of borderline resectable colorectal liver metastasis based on prognostic outcomes. 基于预后结果的边缘可切除结直肠肝转移新定义。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-08 DOI: 10.1007/s00423-024-03492-9
Naokazu Chiba, Shoma Iida, Masashi Nakagawa, Takahiro Gunji, Kei Yokozuka, Toshimichi Kobayashi, Toru Sano, Masatoshi Shigoka, Satoshi Tabuchi, Eiji Hidaka, Shigeyuki Kawachi

Background: Although surgical resection is the curative treatment for colorectal liver metastases (CRLM), the efficacy of neoadjuvant chemotherapy (NAC) has been discussed due to recent remarkable advances in chemotherapy. The definition of borderline resectable (BR) is most important, where neoadjuvant chemotherapy should be administered. This study aimed to examine a new definition of BR CRLM based on the results of the treatment outcomes.

Methods: This study included 127 patients who underwent liver resection for CRLM after exclusion of conversion cases between April 2010 and December 2023. Upfront resection was performed for synchronous and single liver metastasis or metachronous liver metastases. NAC was administered for multiple synchronous liver metastases. In order to find a new definition of BR, we examined the prognostic factors obtained from the treatment outcomes.

Results: CA19-9 level > 37.0 was the only prognostic factor in the upfront group [hazard ratio (HR) 2.386, 95% CI, 1.583-4.769; p = 0.049]. in the NAC group, a maximum tumor diameter ˃3 cm (HR 2.248, 95% CI 1.038-4,867, p = 0.040), CA19-9 level > 37.0 (HR 2.239, 95% CI 1.044-4.800, p = 0.038), and a right-sided primary tumor in the colon (HR 2.770, 95% CI 1.284-5.988, p = 0.009) were identified as significant prognostic factors.

Conclusions: In cases of CRLM, patients with CA19-9 levels > 37.0, or CA19-9 level with < 37.0 but with a primary tumor in the right colon or a maximum tumor diameter of > 3 cm can be defined as BR CRLM and should be treated with NAC.

背景:虽然手术切除是结直肠肝转移瘤(CRLM)的根治性治疗方法,但由于近年来化疗取得了显著进展,新辅助化疗(NAC)的疗效也一直备受讨论。边界可切除(BR)的定义最为重要,在此定义下应进行新辅助化疗。本研究旨在根据治疗结果对边界可切除CRLM进行新的定义:本研究纳入了2010年4月至2023年12月期间因CRLM接受肝脏切除术的127例患者,并排除了转化病例。对同步和单发肝转移瘤或转移性肝转移瘤进行前期切除。对于多发性同步肝转移灶,则采用NAC治疗。为了找到BR的新定义,我们研究了从治疗结果中得出的预后因素:CA19-9水平>37.0是前期组唯一的预后因素[危险比(HR)2.386,95% CI,1.583-4.769;P = 0.049]。在NAC组,肿瘤最大直径˃3厘米(HR 2.248,95% CI 1.038-4,867,P = 0.040)、CA19-9 水平 > 37.0(HR 2.239,95% CI 1.044-4.800,p = 0.038)和结肠右侧原发肿瘤(HR 2.770,95% CI 1.284-5.988,p = 0.009)被认为是显著的预后因素:结论:在CRLM病例中,CA19-9水平> 37.0或CA19-9水平达到3 cm的患者可定义为BR CRLM,应接受NAC治疗。
{"title":"New definition of borderline resectable colorectal liver metastasis based on prognostic outcomes.","authors":"Naokazu Chiba, Shoma Iida, Masashi Nakagawa, Takahiro Gunji, Kei Yokozuka, Toshimichi Kobayashi, Toru Sano, Masatoshi Shigoka, Satoshi Tabuchi, Eiji Hidaka, Shigeyuki Kawachi","doi":"10.1007/s00423-024-03492-9","DOIUrl":"https://doi.org/10.1007/s00423-024-03492-9","url":null,"abstract":"<p><strong>Background: </strong>Although surgical resection is the curative treatment for colorectal liver metastases (CRLM), the efficacy of neoadjuvant chemotherapy (NAC) has been discussed due to recent remarkable advances in chemotherapy. The definition of borderline resectable (BR) is most important, where neoadjuvant chemotherapy should be administered. This study aimed to examine a new definition of BR CRLM based on the results of the treatment outcomes.</p><p><strong>Methods: </strong>This study included 127 patients who underwent liver resection for CRLM after exclusion of conversion cases between April 2010 and December 2023. Upfront resection was performed for synchronous and single liver metastasis or metachronous liver metastases. NAC was administered for multiple synchronous liver metastases. In order to find a new definition of BR, we examined the prognostic factors obtained from the treatment outcomes.</p><p><strong>Results: </strong>CA19-9 level > 37.0 was the only prognostic factor in the upfront group [hazard ratio (HR) 2.386, 95% CI, 1.583-4.769; p = 0.049]. in the NAC group, a maximum tumor diameter ˃3 cm (HR 2.248, 95% CI 1.038-4,867, p = 0.040), CA19-9 level > 37.0 (HR 2.239, 95% CI 1.044-4.800, p = 0.038), and a right-sided primary tumor in the colon (HR 2.770, 95% CI 1.284-5.988, p = 0.009) were identified as significant prognostic factors.</p><p><strong>Conclusions: </strong>In cases of CRLM, patients with CA19-9 levels > 37.0, or CA19-9 level with < 37.0 but with a primary tumor in the right colon or a maximum tumor diameter of > 3 cm can be defined as BR CRLM and should be treated with NAC.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"301"},"PeriodicalIF":2.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proficiency in bariatric surgery may shorten the learning curve for minimally-invasive D2 gastrectomy. 熟练掌握减肥手术可缩短微创 D2 胃切除术的学习曲线。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-08 DOI: 10.1007/s00423-024-03485-8
Sven Flemming, Lars Kollmann, Anna Widder, Joy Backhaus, Johan Friso Lock, Felix Nickel, Alexander Wierlemann, Armin Wiegering, Christoph-Thomas Germer, Florian Seyfried

Introduction: Evidence from Asian studies suggests that minimally-invasive gastrectomy achieves equivalent oncological but improved perioperative outcomes compared to open surgery. Oncological gastric resections are less frequent in European countries. Index procedures may play a role for the learning curve of minimally-invasive gastrectomy. The aim of our study was to evaluate if skills acquired in bariatric surgery allow a safe and oncologically adequate implementation of minimally-invasive gastrectomy in a cohort of european patients.

Methods: In this single-center retrospective study, all patients who received primary bariatric surgery between January 2015 and December 2018 and minimally-invasive surgery for gastric cancer treated from June 2019 to January 2023 were evaluated. Primary endpoints were operation time, lymph node yield and lymph node fractions. Secondary endpoints included postoperative complications and oncological outcomes.

Results: Learning curves for two surgeons with 350 bariatric procedures and 44 minimally-invasive gastrectomies were analyzed. For bariatric surgery, the mean operation time decreased from initially 82 ± 27 to 45 ± 21 min and 118 ± 28 to 81 ± 36 min for sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), while the complication rate remained within the international benchmark. For laparoscopic gastrectomy (n = 30), operation times decreased but then remained stable over time. Operation times for the robotic platform were longer (302 ± 60 vs. 390 ± 48 min; p < 0.001) with the learning curve remaining incomplete after 14 procedures. R0 status was achieved in 95.5% of patients; the mean number of lymph nodes retrieved was 37 ± 14 with no differences between the groups. Complete mesogastric excision was more frequently achieved during the later laparoscopic cases whereas it occurred earlier for the robotic group (p = 0.004). Perioperative morbidity was comparable to the European benchmark. Textbook outcome was achieved in 54.4% of the cases.

Conclusion: In summary, we could demonstrate a successful skill transfer from bariatric surgery to minimally-invasive laparoscopic oncological gastric surgery enabling safe and oncologically adequate minimally-invasive D2 gastrectomy in a central European patient collective.

导言:来自亚洲的研究证据表明,微创胃切除术与开腹手术相比,不仅取得了同等的肿瘤治疗效果,而且改善了围手术期的治疗效果。在欧洲国家,肿瘤性胃切除术并不常见。索引手术可能会影响微创胃切除术的学习曲线。我们研究的目的是评估在减肥手术中获得的技能是否能在欧洲患者群中安全、充分地实施肿瘤微创胃切除术:在这项单中心回顾性研究中,对2015年1月至2018年12月期间接受初级减肥手术以及2019年6月至2023年1月期间接受胃癌微创手术治疗的所有患者进行了评估。主要终点为手术时间、淋巴结产量和淋巴结分数。次要终点包括术后并发症和肿瘤结果:分析了两名外科医生 350 例减肥手术和 44 例微创胃切除术的学习曲线。在减肥手术方面,袖带胃切除术(SG)和Roux-en-Y胃旁路术(RYGB)的平均手术时间分别从最初的82±27分钟和118±28分钟降至45±21分钟和81±36分钟,而并发症发生率仍保持在国际基准范围内。腹腔镜胃切除术(n = 30)的手术时间有所缩短,但随后保持稳定。机器人平台的手术时间更长(302±60 分钟 vs. 390±48 分钟;P 结论:在腹腔镜胃切除术中,并发症发生率保持在国际基准范围内:总之,我们展示了从减肥手术到微创腹腔镜肿瘤胃手术的成功技能转移,在中欧患者群体中实现了安全、肿瘤学充分的微创 D2 胃切除术。
{"title":"Proficiency in bariatric surgery may shorten the learning curve for minimally-invasive D2 gastrectomy.","authors":"Sven Flemming, Lars Kollmann, Anna Widder, Joy Backhaus, Johan Friso Lock, Felix Nickel, Alexander Wierlemann, Armin Wiegering, Christoph-Thomas Germer, Florian Seyfried","doi":"10.1007/s00423-024-03485-8","DOIUrl":"10.1007/s00423-024-03485-8","url":null,"abstract":"<p><strong>Introduction: </strong>Evidence from Asian studies suggests that minimally-invasive gastrectomy achieves equivalent oncological but improved perioperative outcomes compared to open surgery. Oncological gastric resections are less frequent in European countries. Index procedures may play a role for the learning curve of minimally-invasive gastrectomy. The aim of our study was to evaluate if skills acquired in bariatric surgery allow a safe and oncologically adequate implementation of minimally-invasive gastrectomy in a cohort of european patients.</p><p><strong>Methods: </strong>In this single-center retrospective study, all patients who received primary bariatric surgery between January 2015 and December 2018 and minimally-invasive surgery for gastric cancer treated from June 2019 to January 2023 were evaluated. Primary endpoints were operation time, lymph node yield and lymph node fractions. Secondary endpoints included postoperative complications and oncological outcomes.</p><p><strong>Results: </strong>Learning curves for two surgeons with 350 bariatric procedures and 44 minimally-invasive gastrectomies were analyzed. For bariatric surgery, the mean operation time decreased from initially 82 ± 27 to 45 ± 21 min and 118 ± 28 to 81 ± 36 min for sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), while the complication rate remained within the international benchmark. For laparoscopic gastrectomy (n = 30), operation times decreased but then remained stable over time. Operation times for the robotic platform were longer (302 ± 60 vs. 390 ± 48 min; p < 0.001) with the learning curve remaining incomplete after 14 procedures. R0 status was achieved in 95.5% of patients; the mean number of lymph nodes retrieved was 37 ± 14 with no differences between the groups. Complete mesogastric excision was more frequently achieved during the later laparoscopic cases whereas it occurred earlier for the robotic group (p = 0.004). Perioperative morbidity was comparable to the European benchmark. Textbook outcome was achieved in 54.4% of the cases.</p><p><strong>Conclusion: </strong>In summary, we could demonstrate a successful skill transfer from bariatric surgery to minimally-invasive laparoscopic oncological gastric surgery enabling safe and oncologically adequate minimally-invasive D2 gastrectomy in a central European patient collective.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"299"},"PeriodicalIF":2.1,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142391618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between preoperative cephalic vein pathological types and autogenous arteriovenous fistula (AVF) maturation in patients with stage 5 chronic kidney disease. 慢性肾脏病 5 期患者术前头静脉病理类型与自体动静脉瘘(AVF)成熟度的相关性。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-04 DOI: 10.1007/s00423-024-03487-6
Mingjiao Pan, Cuijuan Wang, Yafei Bai, Mingzhi Xu, Yonghui Qi, Ruman Chen

Purpose: To explore the correlation between preoperative cephalic vein pathological types and the maturation of autogenous arteriovenous fistula (AVF) in patients with chronic kidney disease (CKD), providing new ideas and methods for clinical prediction of fistula maturation.

Methods: A retrospective analysis was performed in 80 patients who underwent AVF creation surgery from June 2021 to June 2023 at our hospital. Patients were followed up for 6 months. Patients were classified into the mature group (n = 57) and the power loss group (n = 23) based on the AVF maturation status. Preoperative excised venous tissues were examined using Masson's trichrome staining to compare the intimal area (Ia), medial area (Ma), lumen diameter (Ld), average intimal thickness (Avg It), and average medial thickness (Avg Mt), along with the calculations and comparisons of Ia/Ma, Avg It/Avg Mt ratios. Factors influencing AVF power loss were identified using the multifactorial logistic regression analysis.

Results: Ia, Ia/Ma, and Ld were lower in the power loss group compared to the mature group (P < 0.01). No significant difference was found in Avg Mt and Avg It/Avg Mt levels between the two groups (P > 0.05). The level of Avg It was higher in the power loss group (P < 0.05). Avg It was a risk factor (P < 0.001), while Ld was a protective factor for AVF power loss (P < 0.05).

Conclusion: The levels of Avg It and Ld in preoperative cephalic vein tissue before AVF formation were correlated with AVF power loss. Early monitoring may improve therapeutic outcomes and prognosis of patients with stage 5 CKD.

目的:探讨慢性肾脏病(CKD)患者术前头静脉病理类型与自体动静脉瘘(AVF)成熟度的相关性,为临床预测瘘管成熟度提供新的思路和方法:方法:对2021年6月至2023年6月期间在我院接受动静脉瘘创建手术的80名患者进行回顾性分析。对患者进行了 6 个月的随访。根据动静脉瓣膜成熟情况,将患者分为成熟组(57 人)和动力丧失组(23 人)。术前切除的静脉组织采用马森三色染色法进行检查,比较内膜面积(Ia)、内侧面积(Ma)、管腔直径(Ld)、平均内膜厚度(Avg It)和平均内侧厚度(Avg Mt),并计算和比较 Ia/Ma、Avg It/Avg Mt 比值。使用多因素逻辑回归分析确定了影响 AVF 功率损失的因素:结果:与成熟组相比,功率损失组的 Ia、Ia/Ma 和 Ld 更低(P 0.05)。功率损耗组的 Avg It 水平更高(P 0.05):在 AVF 形成之前,术前头静脉组织中的 Avg It 和 Ld 水平与 AVF 失功相关。早期监测可改善 CKD 5 期患者的治疗效果和预后。
{"title":"Correlation between preoperative cephalic vein pathological types and autogenous arteriovenous fistula (AVF) maturation in patients with stage 5 chronic kidney disease.","authors":"Mingjiao Pan, Cuijuan Wang, Yafei Bai, Mingzhi Xu, Yonghui Qi, Ruman Chen","doi":"10.1007/s00423-024-03487-6","DOIUrl":"https://doi.org/10.1007/s00423-024-03487-6","url":null,"abstract":"<p><strong>Purpose: </strong>To explore the correlation between preoperative cephalic vein pathological types and the maturation of autogenous arteriovenous fistula (AVF) in patients with chronic kidney disease (CKD), providing new ideas and methods for clinical prediction of fistula maturation.</p><p><strong>Methods: </strong>A retrospective analysis was performed in 80 patients who underwent AVF creation surgery from June 2021 to June 2023 at our hospital. Patients were followed up for 6 months. Patients were classified into the mature group (n = 57) and the power loss group (n = 23) based on the AVF maturation status. Preoperative excised venous tissues were examined using Masson's trichrome staining to compare the intimal area (Ia), medial area (Ma), lumen diameter (Ld), average intimal thickness (Avg It), and average medial thickness (Avg Mt), along with the calculations and comparisons of Ia/Ma, Avg It/Avg Mt ratios. Factors influencing AVF power loss were identified using the multifactorial logistic regression analysis.</p><p><strong>Results: </strong>Ia, Ia/Ma, and Ld were lower in the power loss group compared to the mature group (P < 0.01). No significant difference was found in Avg Mt and Avg It/Avg Mt levels between the two groups (P > 0.05). The level of Avg It was higher in the power loss group (P < 0.05). Avg It was a risk factor (P < 0.001), while Ld was a protective factor for AVF power loss (P < 0.05).</p><p><strong>Conclusion: </strong>The levels of Avg It and Ld in preoperative cephalic vein tissue before AVF formation were correlated with AVF power loss. Early monitoring may improve therapeutic outcomes and prognosis of patients with stage 5 CKD.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"296"},"PeriodicalIF":2.1,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transperineal minimally invasive surgery during laparoscopic abdominoperineal resection for low rectal cancer could improve short-term outcomes: A single-institution retrospective cohort study. 腹腔镜腹会阴低位直肠癌切除术中经会阴微创手术可改善短期疗效:一项单一机构的回顾性队列研究。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-04 DOI: 10.1007/s00423-024-03493-8
Akihiro Kondo, Takuro Fuke, Kensuke Kumamoto, Eisuke Asano, Dongping Feng, Hideki Kobara, Keiichi Okano

Purpose: Transperineal minimally invasive surgery (TpMIS) during laparoscopic abdominoperineal resection (APR) is an emerging approach that allows for the precise treatment of lower rectal cancer. However, evidence regarding the efficacy of TpMIS is insufficient. This study evaluated the efficacy of TpMIS during laparoscopic APR for patients with lower rectal cancer.

Methods: Patients who underwent laparoscopic APR with TpMIS (TpMIS group; n = 12) and those who underwent conventional laparoscopic APR for low rectal cancer (conventional group; n = 13) were enrolled consecutively in this retrospective study. Standardized TpMIS was performed at our institution. Patient and tumor characteristics and intraoperative, postoperative, and pathological outcomes were compared between groups. The primary outcome was postoperative perineal wound infection.

Results: No patients in the TpMIS group experienced postoperative perineal wound infection; however, five (38.5%) patients in the conventional group experienced postoperative perineal wound infection (significant difference; p = 0.016). The estimated blood loss (median, 81 mL vs. 463 mL) and incidence of postoperative urinary dysfunction (8.3% vs. 46.1%) were significantly lower in the TpMIS group than in the conventional group. The postoperative hospital stay (median, 13 vs. 20 days) of the TpMIS group was significantly shorter than that of the conventional group. Pathological outcomes did not differ between groups. The positive circumferential resection margin rates of the TpMIS and conventional groups were 8.3% and 15.4%, respectively.

Conclusion: TpMIS during laparoscopic APR was associated with significant improvements in the postoperative outcomes of patients with low rectal cancer.

目的:在腹腔镜腹会阴切除术(APR)期间进行经会阴微创手术(TpMIS)是一种新兴的方法,可精确治疗下段直肠癌。然而,有关TpMIS疗效的证据尚不充分。本研究评估了腹腔镜下直肠癌切除术中TpMIS的疗效:这项回顾性研究连续纳入了接受腹腔镜 APR 并使用 TpMIS 的患者(TpMIS 组;n = 12)和接受传统腹腔镜 APR 治疗低位直肠癌的患者(传统组;n = 13)。标准化的 TpMIS 在我院进行。两组患者和肿瘤特征以及术中、术后和病理结果进行了比较。主要结果是术后会阴伤口感染:结果:TpMIS组没有患者发生术后会阴伤口感染;而传统组有5名(38.5%)患者发生术后会阴伤口感染(差异显著;P = 0.016)。TpMIS 组的估计失血量(中位数,81 毫升对 463 毫升)和术后排尿功能障碍发生率(8.3% 对 46.1%)明显低于传统组。TpMIS 组的术后住院时间(中位 13 天对 20 天)明显短于传统组。两组的病理结果无差异。TpMIS组和传统组的圆周切除边缘阳性率分别为8.3%和15.4%:结论:腹腔镜 APR 期间的 TpMIS 可显著改善低位直肠癌患者的术后效果。
{"title":"Transperineal minimally invasive surgery during laparoscopic abdominoperineal resection for low rectal cancer could improve short-term outcomes: A single-institution retrospective cohort study.","authors":"Akihiro Kondo, Takuro Fuke, Kensuke Kumamoto, Eisuke Asano, Dongping Feng, Hideki Kobara, Keiichi Okano","doi":"10.1007/s00423-024-03493-8","DOIUrl":"https://doi.org/10.1007/s00423-024-03493-8","url":null,"abstract":"<p><strong>Purpose: </strong>Transperineal minimally invasive surgery (TpMIS) during laparoscopic abdominoperineal resection (APR) is an emerging approach that allows for the precise treatment of lower rectal cancer. However, evidence regarding the efficacy of TpMIS is insufficient. This study evaluated the efficacy of TpMIS during laparoscopic APR for patients with lower rectal cancer.</p><p><strong>Methods: </strong>Patients who underwent laparoscopic APR with TpMIS (TpMIS group; n = 12) and those who underwent conventional laparoscopic APR for low rectal cancer (conventional group; n = 13) were enrolled consecutively in this retrospective study. Standardized TpMIS was performed at our institution. Patient and tumor characteristics and intraoperative, postoperative, and pathological outcomes were compared between groups. The primary outcome was postoperative perineal wound infection.</p><p><strong>Results: </strong>No patients in the TpMIS group experienced postoperative perineal wound infection; however, five (38.5%) patients in the conventional group experienced postoperative perineal wound infection (significant difference; p = 0.016). The estimated blood loss (median, 81 mL vs. 463 mL) and incidence of postoperative urinary dysfunction (8.3% vs. 46.1%) were significantly lower in the TpMIS group than in the conventional group. The postoperative hospital stay (median, 13 vs. 20 days) of the TpMIS group was significantly shorter than that of the conventional group. Pathological outcomes did not differ between groups. The positive circumferential resection margin rates of the TpMIS and conventional groups were 8.3% and 15.4%, respectively.</p><p><strong>Conclusion: </strong>TpMIS during laparoscopic APR was associated with significant improvements in the postoperative outcomes of patients with low rectal cancer.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"297"},"PeriodicalIF":2.1,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed primary skin closure reduce surgical site infection following surgery for gastrointestinal perforation: A systematic review and meta-analysis. 延迟初级皮肤闭合可减少胃肠道穿孔手术后的手术部位感染:系统回顾和荟萃分析。
IF 2.1 3区 医学 Q2 SURGERY Pub Date : 2024-10-04 DOI: 10.1007/s00423-024-03489-4
Cangyuan Zhang, Jiajie Zhou, Longhe Sun, Daofu Zhang, Lei Xia, Shuai Zhao, Yayan Fu, Ruiqi Li

Background: Following surgery for Gastrointestinal (GI) perforation, there is an increased occurrence of Surgical Site Infections (SSI). The beneficial effect of employing delayed primary skin closure (DPC) on severely contaminated incisions subsequent to surgery for GI perforation remains unverified.

Objective: To systematically evaluate the advantages of the DPC management in surgery for GI perforation.

Methods: A literature search was performed using ClinicalTrials.gov, Pubmed, Embase, Cocharane, and Web of Science identified all eligible English-language studies related to surgery for GI perforation through October 2023. Randomized clinical trials (RCTs) comparing DPC with primary skin closure (PC) in surgery for GI perforation were included. Two investigators independently performed the inclusion work, and a third investigator was consulted for resolving conflicts. Data were extracted by multiple independent investigators and pooled in a random-effects model. The primary outcome was SSI, defined in accordance with the original studies. The secondary outcome was the length of stay (LOS).

Results: Final analysis included 12 RCTs which included a total of 903 patients were randomizing divided into either DPC or PC, including 289 patients with gastroduodenal perforation (32%), 144 patients with small intestine perforation (15.96%), 60 patients with colon perforation (6.64%), and 410 patients with appendix perforation (45.4%). The rates of SSI was significantly decreased after DPC management (OR:0.31, 95%CI:0.15-0.63, p < 0.01), no significant differences were observed between the DPC group and PC group in terms of LOS (MD: - 0.37, 95% CI: - 1.91-1.16, p = 0.63).

Conclusion: These results point to the efficacy of DPC management in reducing SSI in patients under surgery for GI perforation, and this strategy did not increase the LOS. This systematic review and meta-analysis may contribute to informed decision-making in the management of severely contaminated wounds associated with GI perforation.

背景:胃肠道(GI)穿孔手术后,手术部位感染(SSI)的发生率增加。对消化道穿孔手术后严重污染的切口采用延迟原位皮肤闭合术(DPC)的有益效果仍未得到证实:目的:系统评估消化道穿孔手术中 DPC 管理的优势:方法:使用 ClinicalTrials.gov、Pubmed、Embase、Cocharane 和 Web of Science 进行文献检索,确定了截至 2023 年 10 月与消化道穿孔手术相关的所有符合条件的英文研究。研究纳入了在消化道穿孔手术中比较 DPC 与原发性皮肤闭合术 (PC) 的随机临床试验 (RCT)。两位研究者独立完成了纳入工作,并咨询了第三位研究者以解决冲突。数据由多名独立研究者提取,并通过随机效应模型进行汇总。主要结果是 SSI,其定义与原始研究一致。次要结果是住院时间(LOS):最终分析包括 12 项研究,共有 903 名患者被随机分为 DPC 或 PC,其中包括 289 名胃十二指肠穿孔患者(32%)、144 名小肠穿孔患者(15.96%)、60 名结肠穿孔患者(6.64%)和 410 名阑尾穿孔患者(45.4%)。经过 DPC 处理后,SSI 的发生率明显降低(OR:0.31,95%CI:0.15-0.63,p 结论:DPC 对肠穿孔患者的疗效显著:这些结果表明,DPC 处理能有效减少因消化道穿孔而接受手术的患者的 SSI,而且这种策略不会增加患者的住院时间。这项系统性回顾和荟萃分析可能有助于在处理与消化道穿孔相关的严重污染伤口时做出明智的决策。
{"title":"Delayed primary skin closure reduce surgical site infection following surgery for gastrointestinal perforation: A systematic review and meta-analysis.","authors":"Cangyuan Zhang, Jiajie Zhou, Longhe Sun, Daofu Zhang, Lei Xia, Shuai Zhao, Yayan Fu, Ruiqi Li","doi":"10.1007/s00423-024-03489-4","DOIUrl":"10.1007/s00423-024-03489-4","url":null,"abstract":"<p><strong>Background: </strong>Following surgery for Gastrointestinal (GI) perforation, there is an increased occurrence of Surgical Site Infections (SSI). The beneficial effect of employing delayed primary skin closure (DPC) on severely contaminated incisions subsequent to surgery for GI perforation remains unverified.</p><p><strong>Objective: </strong>To systematically evaluate the advantages of the DPC management in surgery for GI perforation.</p><p><strong>Methods: </strong>A literature search was performed using ClinicalTrials.gov, Pubmed, Embase, Cocharane, and Web of Science identified all eligible English-language studies related to surgery for GI perforation through October 2023. Randomized clinical trials (RCTs) comparing DPC with primary skin closure (PC) in surgery for GI perforation were included. Two investigators independently performed the inclusion work, and a third investigator was consulted for resolving conflicts. Data were extracted by multiple independent investigators and pooled in a random-effects model. The primary outcome was SSI, defined in accordance with the original studies. The secondary outcome was the length of stay (LOS).</p><p><strong>Results: </strong>Final analysis included 12 RCTs which included a total of 903 patients were randomizing divided into either DPC or PC, including 289 patients with gastroduodenal perforation (32%), 144 patients with small intestine perforation (15.96%), 60 patients with colon perforation (6.64%), and 410 patients with appendix perforation (45.4%). The rates of SSI was significantly decreased after DPC management (OR:0.31, 95%CI:0.15-0.63, p < 0.01), no significant differences were observed between the DPC group and PC group in terms of LOS (MD: - 0.37, 95% CI: - 1.91-1.16, p = 0.63).</p><p><strong>Conclusion: </strong>These results point to the efficacy of DPC management in reducing SSI in patients under surgery for GI perforation, and this strategy did not increase the LOS. This systematic review and meta-analysis may contribute to informed decision-making in the management of severely contaminated wounds associated with GI perforation.</p>","PeriodicalId":17983,"journal":{"name":"Langenbeck's Archives of Surgery","volume":"409 1","pages":"298"},"PeriodicalIF":2.1,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142372225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Langenbeck's Archives of Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1